Welcome : Guest

Guided Therapeutics, Inc. (USA) - Facts, Figures and Analytical Insights

Abstract

This report presents quick facts about Guided Therapeutics, Inc., which is principally a Medical Technology Company. Illustrated with 75 tables, the report showcases the company's recent news stories and events, key markets and market position as against its competitors operating in the industry.

Code: PCP-43292
Price: $3500
Company Type: Public
Pages: 78
Date: November 2016
Market Data Tables: 75

 NOTE : Select the checkbox below, and click Add to Cart button to add this report to your shopping cart.
Medical Devices......3
Table 1: Global Medical Device and Diagnostics Market (2014) in US$ Million......3
Table 2: Medical Device and Diagnostics Market by Product Segment Worldwide (2015) - Percentage Share Breakdown by Value Sales for Anesthesia & Respiratory, Cardiology, Dental, Diabetic Care, Diagnostic Imaging, Drug Delivery, Ear, Nose, and Throat (ENT), Endoscopy, General & Plastic Surgery, In Vito Diagnostics, Nephrology, Neurology, Opthalmics, Orthopedics, Wound Management, and Others......4
Table 3: Medical Devices & Diagnostics (MD&D)'s Market by Country Worldwide (2015) - Percentage Share Breakdown by Value Sales for Brazil, Canada, China, France, Germany, Italy, Japan, Russia, Spain, U.S., UK, and Others......5
Table 4: Global Medical Devices Market (2014) in US$ Million......6
Table 5: Medical Device Industry Market by Product Worldwide (2015) - Percentage Share Breakdown by Value Sales for Gloves, Syringes, Catheters, First Aid Kit, Bandage Dressings, Surgical Tools, Equipment, Wheelchair, Electric Scooter, Blood Pressure Monitors, Glucose Meters, Thermometers, Contact lenses, X-ray, ECG, Ultrasound, and MRI Physiological Monitors......7
Table 6: Medical Device Industry Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value Sales for Consumables Supplies, Homecare & Consumer Products, Hospital-Based Diagnosis Products, and Hospital-Based Treatment Products......8
Table 7: Medical Device Sales by Region Worldwide (2015) - Percentage Share Breakdown by Value for Brazil, China, India, Russia, and Others......9
Table 8: Medical Devices Market by Country Worldwide (2015) - Percentage Share Breakdown by Value Sales for Brazil, China, Germany, India, Japan, Russia, Spain, UK, USA, and Others......10
Table 9: Medical Devices Market by Region Worldwide (2015) - Percentage Share Breakdown by Value Sales for Americas, Asia-Pacific, Europe, and Others......11
Table 10: Medical Devices Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for Cardiovascular, Dental, Diabetes SMBG & Int. Sol, Drug Delivery, Endoscopy, Energy-Based, Radiotherapy, Imaging, In-Vitro Diagnostics, Orthopedics, Surgical Instrument, Urology & Renal, Vision, Wound Care, and Others......12
Table 11: Medical Equipment and Supplies Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value for Dental Surgery & Equipment, Disposable Equipment & Supplies, In Vitro Diagnostics, Ophthalmic Equipment, Otologic & Technical Aids, and Other......13
Table 12: Medical Devices Market by Country in Asia-Pacific (2015) - Percentage Share Breakdown by Value Sales for Australia, China, India, Japan, Korea, Malaysia, Taiwan, Thailand, and Vietnam......14
Table 13: Medical Device Market by Type in Australia (2015) - Percentage Share Breakdown by Value for Consumables, Dental Products, Diagnostic imaging, Orthopaedica and Prosthetics, Patient Aids, and Others......15
Table 14: Medical and Surgical Equipment Market by Category in Australia (2015) - Percentage Breakdown by Value for Dental Equipment and Supplies, Laboratory Apparatus and Furniture, Surgical and Medical Instruments, Surgical Appliances and Supplies, and Other Medical and Surgical Equipment......16
Table 15: Medical Devices Market by Segment in China (2015) - Percentage Share Breakdown by Value Sales for Consumables, Dental, Diagnostic Imaging, Orthopaedic, Patient Aids, and Others......17
Table 16: Medical Devices Market in China (2014) in US$ Million......18
Table 17: Medical Devices Sales by Product in China (2015) - Percentage Market Share Breakdown by Value for Consumables, In Vitro Diagnostics, and Medical Equipment......19
Table 18: Medtech Market by Product in China (2015) - Percentage Share Breakdown by Value Sales for Capital Equipment, Implantables, In-Vitro Diagnostics, Personal Medical Equipment, Other High-Value Medical Devices, and Others......20
Table 19: Medical Equipment Market by Type in India (2015) - Percentage Share Breakdown by Value for Home care, Imaging (CT (Computed Tomography) Scan, Doppler, MRI (Magnetic Resonance Imaging), Ultrasound, X-Ray, Others), Patient Monitoring, and Therapeutic......21
Table 20: Medical Device Market by Type in New Zealand (2015) - Percentage Share Breakdown by Value for Consumables, Dental Products, Diagnostic imaging, Orthopaedica and Prosthetics, Patient Aids, and Others......22
Table 21: Medical Device Industry Market by Product in Taiwan (2015) - Percentage Share Breakdown by Value Sales for Gloves, Syringes, Catheters, First Aid Kit, Bandage Dressings, Surgical Tools, Equipment, Wheelchair, Electric Scooter, Blood Pressure Monitors, Glucose Meters, Thermometers, Contact lenses, and X-ray, ECG, Ultrasound, MRI, Physiological Monitors......23
Table 22: Medical Device Industry Market by Segment in Taiwan (2015) - Percentage Share Breakdown by Value Sales for Consumables Supplies, Homecare & Consumer Products, Hospital-Based Diagnosis Products, and Hospital-Based Treatment Products......24
Cancer Drugs......25
Table 23: Oncology/Hematology Drugs Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for Blood Cell Factors, Chemopreventatives, Chemotherapeutics, Mabs, Targeted Therapies, and Others......25
Table 24: Oncology Drug Market by Region Worldwide (2015) - Percentage Share Breakdown by Value for European Union Five, Japan, US and Others......26
Cancer Market......27
Table 25: Cancer Care Expenditure by Site Worldwide (2015) - Percentage Share Breakdown for Breast, Colorectal, Lymphoma, Lung, Prostate and Others......27
Table 26: Cancer Market by Category Worldwide (2015) - Percentage Share Breakdown by Value for Heme, Lung, Prostate, and Others......28
Table 27: Oncology Market by Cancer Type Worldwide (2015) - Percentage Share Breakdown by Value for Breast Cancer, Metastatic Colorectal Cancer, Non-Small Cell Lung Cancer, and Others......29
Table 28: Clinical Oncology Market by Region Worldwide (2015) - Percentage Share Breakdown by Value Sales for US, and Others......30
Table 29: Hereditary Oncology Market by Region Worldwide (2015) - Percentage Share Breakdown by Value Sales for US, and Others......31
Table 30: Cancer Market by Type in China (2015) - Percentage Share Breakdown by Value for Breast, Colorectal, Esophagus, Liver, Lung, Stomach and Others......32
Table 31: Oncology Market by Category in China (2015) - Percentage Share Breakdown by Value for Anti- Tumor Agents, Hormone Therapy, Immuno Suppresants and Immunostimulants......33
Table 32: Oncology Market by Segment in the US (2015) - Percentage Share Breakdown by Value for Solid Tumor and Others......34
Cancer Patients......35
Table 33: Breast Cancer Diagnoses by Hospital Type in the US (2015) - Percentage Share Breakdown by Volume for Community, Comprehensive, Teaching and Research, and Others......35
Table 34: No. of Colorectal Cancer Patients by Region Worldwide (2015) - Percentage Market Share Breakdown for Asia, Australia, Europe, and US......36
Table 35: No. of Invasive Breast Cancer Patients by Category Worldwide (2015) - Percentage Market Share Breakdown for Stage I and Stage II-III......37
Table 36: No. of Primary Liver Cancer Patients by Region Worldwide (2015) - Percentage Market Share Breakdown for Asia, Australia, Europe, and US......38
Table 37: No. of Chronic Lymphocytic Leukemia (CLL) (1L) Patients by Category Worldwide (2015) - Percentage Market Share Breakdown for Imbruvica PCYC, Rituxan, Gazyva ROG, and Others......39
Table 38: No. of Cutaneous Melanoma Patients by Region Worldwide (2015) - Percentage Market Share Breakdown for Asia, Australia, Europe, and US......40
Table 39: No. of Ocular Melanoma Patients by Region Worldwide (2015) - Percentage Market Share Breakdown for Asia, Australia, Europe, and US......41
Table 40: Female Mortality by Cancer Type in China (2015) - Percentage Market Share Breakdown by Volume for Lung, Breast, Colon, Rectum and Anus, Intestine, Liver, and Others......42
Table 41: Male Mortality by Cancer Type in China (2015) - Percentage Market Share Breakdown by Volume for Colon, Colon, Rectum and Anus, Intestine, Liver, Lung, and Others......43
Table 42: No. of Chronic Lymphocytic Leukemia (CLL) (1L) Patients by Category in European Union (2015) - Percentage Market Share Breakdown for Rituxan, Gazyva, and Others......44
Table 43: No. of Chronic Lymphocytic Leukemia (CLL) (R/R) Patients by Category in European Union (2015) - Percentage Market Share Breakdown for Rituxan, Gazyva, and Others......45
Table 44: No. of Cancer Patients by Type in the US (2015) - Percentage Market Share Breakdown for Colorectal Cancer (CRC), Melanoma, Non-Squamous Non-Small-Cell Lung Cancer (NSCLC), Ovarian, Prostate, Renal Cell Carcinoma (RCC), and Squamous Non-Small-Cell Lung Cancer (NSCLC)......46
Table 45: Number of Cancer Patients by Type in the US (2015) - Percentage Share Breakdown by Volume for Bladder Cancer, Breast Cancer (Female), Colon and Rectum Cancer, Endometrial Cancer, Kidney and Renal Pelvis Cancer, Lung and Bronchus Cancer, Melanoma of the Skin, Non-Hodgkin Lymphoma, Prostate Cancer, and Thyroid Cancer......47
Table 46: No. of Cancer Patients Death by Type in the US (2015) - Percentage Share Breakdown for Breast, Colorectal, Lung, Melanoma, and Prostate......48
Table 47: New Patients with Cancer by Site in the US (2015) - Percentage Market Share Breakdown by volume for Colorectal, Lung and Bronchus, Melanoma, Pancreas, and Others......49
Table 48: Number of Cancer Patients by Type Worldwide (2015) - Percentage Share Breakdown by Volume for Bladder, Breast, Cervix Uteri, Colorectum, Liver, Lung, Non-Hodgkin lymphoma, Oesophagus, Prostate, and Stomach......50
Table 49: No. of Bladder Cancer Patients by Category in the US (2015) - Percentage Market Share Breakdown for Invasive Patients, and Non-Invasive Patients......51
Table 50: No. of Invasive Breast Cancer Patients by Category in the US (2015) - Percentage Market Share Breakdown for Stage I and Stage II-III......52
Table 51: New Patients with Cancer in Stage 3/4 by Site in the US (2015) - Percentage Market Share Breakdown by Volume for Colorectal, Lung and Bronchus, Pancreas and Others......53
Table 52: No. of Solid Cancer Tumor Patients by Type Worldwide (2015) - Percentage Share Breakdown for Breast Cancer, Colorectal Cancer, Lung Cancer, Melanoma, and Prostate Cancer......54
Table 53: No. of Non Small Cell Lung Cancer Patients by Category in the US (2015) - Percentage Market Share Breakdown for Stage I, Stage II-III, Stage III-IV, and Undiagnozed......55
Cervical Cancer......56
Table 54: Cervical Cancer Market by HPV Type in England (2015) - Percentage Share Breakdown by Value for HPV 16, HPV 18, HPV 33, HPV 45, and Others......56
Table 55: Cervical Cancer Market by HPV Type in Europe (2015) - Percentage Share Breakdown by Value for HPV 16, HPV 18, HPV 31, HPV 33, and Others......57
Hematological Cancer......58
Table 56: Hematological Cancer by Category Worldwide (2015) - Percentage Market Share Breakdown by Value Sales for Chronic Lymphocytic Leukemia (CLL), Multiple Myeloma (MM), and Non-Hodgkin’s Lymphoma (NHL)......58
Skin Cancer......59
Table 57: Skin Cancer by Type Worldwide (2015) - Percentage Market Share Breakdown by Volume for Basal Cell Carcinomas, Melanoma, and Squamous Cell Carcinomas......59
Cancer-Associated Mucositis......60
Table 58: Cancer-Associated Mucositis Market by Activity Worldwide (2015) - Percentage Share Breakdown by Value for Breast, Colorectal, Head and Neck, Non-Small Cell Lung cancer and Others......60
Chronic Myelogenous Leukemia (CML)......61
Table 59: Chronic Myelogenous Leukemia (CML) Market by Region Worldwide (2015) - Percentage Share Breakdown by Value Sales for Asia-Pacific, Canada, European Union, Japan, USA, and Others......61
Multiple Myeloma......62
Table 60: Multiple Myeloma by Age Group Worldwide (2015) - Percentage Share Breakdown by No. of New Cases for 45-54, 55-64, 65-74, 75-84, >84, and Others......62
Table 61: Multiple Myeloma Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for Kyprolis AMGN, Pomalyst CELG, Revlimid CELG, Thalomid CELG, and Velcade TKD/JNJ......63
Medical Device Sterilization......64
Table 62: Market Shares of Leading Medical Device Sterilization Equipment Manufacturers by Value Sales Worldwide (2014) - Percentage Share Breakdown for Bioster A.S., Sterigenics International LLC, Steris-Isomedix, Inc., Synergy Health Plc, In-House Services, and Others......64
Table 63: Low-temperature Central Sterilization Market by Region Worldwide (2015) - Percentage Share Breakdown by Value for Canada, Europe, U.S, and Rest of the World......65
Table 64: Low-temperature Central Sterilization Market by Technology Worldwide (2015) - Percentage Share Breakdown by Volume for Ethylene Oxide (EO), Hydrogen Peroxide (HP), and Low-temperature Steam Formaldehyde (LTSF)......66
Table 65: Market Shares of Leading Medical Device Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for Abbott Laboratories, Baxter International, Inc., Becton, Dickinson and Company, Boston Scientific Corporation, Covidien Public Limited Company, GE Healthcare, Johnson & Johnson, Koninklijke Philips N.V., Medtronic, Inc., Siemens Healthcare Corporation, and Others......67
Table 66: Market Shares of Leading Medical Device Manufacturers in the US (2014) - Percentage Breakdown by Value for Boston Scientific, Edwards Life sciences, Medtronic, St. Jude Medical and Others......68
Cancer Drugs......69
Table 67: Market Shares of Leading Oncology Product Manufacturers Worldwide (2015) - Percentage Breakdown by Value for Fresenius SE & Co., and Others......69
Table 68: Market Shares of Leading Oncology/Hematology Therapeutic Providers by Value Sales Worldwide (2014) - Percentage Breakdown for AbbVie, Amgen, Inc., AstraZeneca Plc, Bristol-Myers Squibb Company, Eli Lilly and Company, F. Hoffmann-La Roche AG, GlaxoSmithKline Plc, Johnson & Johnson, Merck Ltd., Novartis AG, Pfizer, Inc., Sanofi S.A., and Others......70
Table 69: Market Shares of Leading Oncology Drug Manufacturers in China (2015) - Percentage Share Breakdown by Value for Astrazeneca, Jiangsu Hengrui Medicine Co., Ltd., Roche Group and Others......71
Table 70: Anti-Cancer Drugs Market by Product Type in China (2015) - Percentage Share Breakdown by Value for Anastrozole, Capecitabine, Cetuximab, Compound kushen, Docetaxel, Epirubicin, Erlotinib, Gefitinib, Gemcitabine, Goserelin, Interferon α-2a, Interferon α-2b, Irinotecan, Kangai, Lentinan, Letrozole, Oxaliplatin, Paclitaxel, Pemetrexed, Pidotimod, RhG-CSF, RhIL-2, Rituximab, Sorafenib, Sshenqi Fuzheng, Thymopentin, Thymosin a1, Trastuzmmab, Triptorelin, TS-1, and Others......72
Table 71: Anti-Cancer Drugs Market by Type in China (2015) - Percentage Share Breakdown by Value for Alkylating Agents, Antibiotics, Antimetabolites, Hormonal Agents, Immunostimulant, Plant Alkaloids, and Others......73
Breast Cancer Drugs......74
Table 72: Market Shares of Leading Breast Cancer Drugs by Value Sales in China (2014) - Percentage Breakdown for Alkylating Agents, Antimetabolite, Antitumor Antibiotics, Antitumor Antihormone, Antitumor Botanicals, Monoclonal Antibodies, Targeted Small Molecule Agents, and Others......74
Relapsed/Refractory (RR) Chronic Lymphocytic Leukemia (CLL)......75
Table 73: Market Shares of Leading Drugs for Treatment of Relapsed/Refractory (RR) Chronic Lymphocytic Leukemia (CLL) in the US (2015) - Percentage Share Breakdown by Value for Ibrutinib, Idelalisib and Others......75
Relapsed/Refractory (RR) Indolent Non-Hodgkin's Lymphoma (iNHL)......76
Table 74: Market Shares of Leading Drugs for Treatment of Relapsed/Refractory (RR) Indolent Non-Hodgkin's Lymphoma (iNHL) in the US (2015) - Percentage Share Breakdown by Value for Ibrutinib, Idelalisib and Others......76
Table 75: Market Shares of Leading Drugs for Treatment of Relapsed/Refractory Aggressive Non-Hodgkin Lymphoma (R/R- aNHL) in the US (2015) - Percentage Share Breakdown by Value for Ibrutinib and Others......77